BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23570653)

  • 21. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
    Wang YX; Cai H; Jiang G; Zhou TB; Wu H
    Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silibinin alleviates high glucose-suppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3K/Akt signaling.
    Ying X; Chen X; Liu H; Nie P; Shui X; Shen Y; Yu K; Cheng S
    Eur J Pharmacol; 2015 Oct; 765():394-401. PubMed ID: 26362750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK.
    Jeon ES; Lee MJ; Sung SM; Kim JH
    J Cell Biochem; 2007 Apr; 100(6):1536-47. PubMed ID: 17131361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
    Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
    Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.
    Hsieh YS; Chu SC; Yang SF; Chen PN; Liu YC; Lu KH
    Carcinogenesis; 2007 May; 28(5):977-87. PubMed ID: 17116726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.
    Sui H; Shi C; Yan Z; Li H
    Drug Des Devel Ther; 2015; 9():3183-90. PubMed ID: 26124641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression.
    Ezhilarasan D; Evraerts J; Sid B; Calderon PB; Karthikeyan S; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):80-87. PubMed ID: 28119262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
    Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
    Shi Y; Sahu RP; Srivastava SK
    BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer.
    Pashaei-Asl F; Pashaei-Asl R; Khodadadi K; Akbarzadeh A; Ebrahimie E; Pashaiasl M
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1483-1487. PubMed ID: 28884602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
    Cui W; Gu F; Hu KQ
    World J Gastroenterol; 2009 Apr; 15(16):1943-50. PubMed ID: 19399925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK.
    Chen YL; Loh SH; Chen JJ; Tsai CS
    Eur J Pharmacol; 2012 Apr; 680(1-3):88-94. PubMed ID: 22329895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silibinin induced-autophagic and apoptotic death is associated with an increase in reactive oxygen and nitrogen species in HeLa cells.
    Fan S; Li L; Chen S; Yu Y; Qi M; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2011 Nov; 45(11-12):1307-24. PubMed ID: 21875385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.
    Wu JX; Hong YH; Yang XG
    J Biol Inorg Chem; 2016 Dec; 21(8):919-929. PubMed ID: 27614430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway.
    Pang Y; Si M; Sun B; Niu L; Xu X; Lu T; Yuan H; Lou H
    Food Chem Toxicol; 2014 Jul; 69():163-74. PubMed ID: 24751974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt.
    Moon DO; Park SY; Heo MS; Kim KC; Park C; Ko WS; Choi YH; Kim GY
    Int Immunopharmacol; 2006 Dec; 6(12):1796-807. PubMed ID: 17052670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.